Toward an evidence-based toxicology

被引:103
作者
Hoffmann, S. [1 ]
Hartung, T. [1 ]
机构
[1] European Commiss, JRC, Inst Hlth & Consumer Protect, ECVAM, I-21020 Ispra, VA, Italy
关键词
evidence-based; reliability; test assessment; toxicology; validation; relevance;
D O I
10.1191/0960327106het648oa
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
The increasing demands on toxicology of large-scale risk assessment programmes for chemicals and emerging or expanding areas of chemical use suggest it is timely to review the toxicological toolbox. Like in clinical medicine, where an evidence-based medicine (EBM) is critically reviewing traditional approaches, toxicology has the opportunity to reshape and enlarge its methodology and approaches on the basis of compounded scientific knowledge. Such revision would have to be based on structured reviews of current practice, ie, assessment of test performance characteristics, mechanistic understanding, extended quality assurance, formal validation and the use of integrated testing strategies. This form of revision could optimize the balance between safety, costs and animal welfare, explicitly stating and, where possible, quantifying uncertainties. After a self-critical reassessment of current practices and evaluation of the thus generated information, such an evidence-based toxicology (EBT) promises to make better use of resources and to increase the quality of results, facilitating their interpretation. It shall open up hazard and also risk assessments to new technologies, flexibly accommodating current and future mechanistic understanding. An EBT will be better prepared to answer the continuously growing safety demands of modern societies.
引用
收藏
页码:497 / 513
页数:17
相关论文
共 157 条
[51]   The ECVAM international validation study on in vitro tests for skin corrosivity. 2. Results and evaluation by the management team [J].
Fentem, JH ;
Archer, GEB ;
Balls, M ;
Botham, PA ;
Curren, RD ;
Earl, LK ;
Esdaile, DJ ;
Holzhutter, HG ;
Liebsch, M .
TOXICOLOGY IN VITRO, 1998, 12 (04) :483-524
[52]   THE CARCINOGENESIS BIOASSAY IN PERSPECTIVE - APPLICATION IN IDENTIFYING HUMAN CANCER HAZARDS [J].
FUNG, VA ;
BARRETT, JC ;
HUFF, J .
ENVIRONMENTAL HEALTH PERSPECTIVES, 1995, 103 (7-8) :680-683
[53]   Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens? [J].
Gaylor, DW .
REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2005, 41 (02) :128-133
[54]  
Gerberick G F, 2000, Am J Contact Dermat, V11, P3
[55]   Development of a decision support system for the introduction of alternative methods into local irritancy/corrosivity testing strategies. Creation of fundamental rules for a decision support system [J].
Gerner, I ;
Zinke, S ;
Graetschel, G ;
Schlede, E .
ATLA-ALTERNATIVES TO LABORATORY ANIMALS, 2000, 28 (05) :665-698
[56]   The CFTA evaluation of alternatives program: An evaluation of in vitro alternatives to the Draize primary eye irritation test. (Phase III) surfactant-based formulations [J].
Gettings, SD ;
Lordo, RA ;
Hintze, KL ;
Bagley, DM ;
Casterton, PL ;
Chudkowski, M ;
Curren, RD ;
Demetrulias, JL ;
Dipasquale, LC ;
Earl, LK ;
Feder, PI ;
Galli, CL ;
Glaza, SM ;
Gordon, VC ;
Janus, J ;
Kurtz, PJ ;
Marenus, KD ;
Moral, J ;
Pape, WJW ;
Renskers, KJ ;
Rheins, LA ;
Roddy, MT ;
Rozen, MG ;
Tedeschi, JP ;
Zyracki, J .
FOOD AND CHEMICAL TOXICOLOGY, 1996, 34 (01) :79-117
[57]   Potential human cancer risks from exposure to PCBs: A tale of two evaluations [J].
Golden, R ;
Doull, J ;
Waddell, W ;
Mandel, J .
CRITICAL REVIEWS IN TOXICOLOGY, 2003, 33 (05) :543-580
[58]   The costly illusion of regulating unknowable risks [J].
Gori, GB .
REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2001, 34 (03) :205-212
[59]   Data quality in predictive toxicology: Reproducibility of rodent carcinogenicity experiments [J].
Gottmann, E ;
Kramer, S ;
Pfahringer, B ;
Helma, C .
ENVIRONMENTAL HEALTH PERSPECTIVES, 2001, 109 (05) :509-514
[60]   Uses and abuses of screening tests [J].
Grimes, DA ;
Schulz, KF .
LANCET, 2002, 359 (9309) :881-884